Related Experiment Video
Updated: Aug 22, 2025
11:17
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Published on: August 11, 2018
12.1K
A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine
Syeda S Nida1, Gabriel J Tobon2, Morgan Wilson3
1Internal Medicine, Southern Illinois University School of Medicine, Springfield, USA.
Cureus
|November 7, 2022
Summary
A case study found bullous pemphigoid, a blistering skin condition, can occur after COVID-19 vaccination. Early steroid treatment led to significant improvement, suggesting a positive prognosis for this vaccine-related autoimmune skin reaction.
Area of Science:
- Dermatology
- Immunology
- Vaccinology
Background:
- The clinical manifestations of COVID-19 infection and vaccination continue to be documented.
- Cutaneous adverse events following COVID-19 vaccination are increasingly reported, necessitating further investigation into their clinical spectrum and management.
Observation:
- A 70-year-old male developed a painful, pruritic blistering rash two days post-second dose of the Pfizer COVID-19 vaccine.
- Clinical examination revealed tense bullae, and diagnostic workup including biopsy and direct immunofluorescence confirmed bullous pemphigoid.
Findings:
- The patient's bullous pemphigoid significantly improved with corticosteroid therapy.
- This case adds to the literature on autoimmune skin conditions, specifically bullous pemphigoid, arising after mRNA COVID-19 vaccination.
Implications:
- Bullous pemphigoid following COVID-19 vaccination appears responsive to steroid treatment with an excellent prognosis.
- While further data is required, the benefits of COVID-19 vaccination likely outweigh the risks of rare cutaneous side effects like bullous pemphigoid.
Related Concept Videos
00:42Cross-reactivity
31.4K
Overview
31.4K
01:27Allergic Drug Reactions
931
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
931
01:51Vaccinations
45.2K
Overview
45.2K
02:06Allergic Reactions
28.1K
Overview
28.1K
01:25Endocarditis II: Clinical Features of Infective Endocarditis
22
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
22
01:23Skin Diseases and Disorders
4.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.0K